3D printing functional graphenic materials (FGMs) as intrinsically inductive scaffolds for bone regeneration

3D 打印功能石墨烯材料 (FGM) 作为骨再生的本征感应支架

基本信息

  • 批准号:
    10259656
  • 负责人:
  • 金额:
    $ 19.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-09 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

Abstract Severe bone injury can occur due to traumatic events such as automobile accidents or battlefield injuries, and every year millions of patients in the United States undergo procedures, often invasive and painful, every year to correct these deformities. Currently, autologous tissue transplantation or implantation of prosthetic devices is used as a therapeutic treatment for large defect areas. These procedures are limited by a lack of donor tissue, donor site morbidity, potential for graft rejection, susceptibility to infection, and feasibility of transplantation. Non- resorbable materials, such as titanium, remain as a permanent implant material and lack the ability to remodeled for integration with native tissue. We propose a new class of 3D printed graphenic scaffold to mimic the complexity of bone and induce the native regenerative response. Functional graphenic materials (FGMs) are a novel class of potential scaffold material that offer tunable mechanical properties, degradability, and surface chemistry, which together can be used to control bioactivity. The Sydlik group has developed several novel FGMs that inherently induce osteogenesis in vitro and in vivo. Specifically, we have shown that calcium phosphate graphene (CaPG) releases bioinstructive counter ions, Ca2+ and PO43- , to spontaneously induces osteogenesis in vivo in a mouse model (PNAS, 2019). However, the application of FGMs as biomaterials is restricted due to insufficient control of the chemical interface and limited processing methods. Thus, to make this technology translatable, we need a fabrication technique that can create volumetric constructs to fill large bone defects. 3D printing is uniquely positioned to address this challenge because scaffolds can be custom printed to match the patients defect site. This proposal seeks to advance bioactive osteogenic CaPG into instructive scaffolds that achieve significantly improved cranial bone regeneration.
摘要 严重的骨骼损伤可因创伤事件而发生,如车祸或战场伤害,以及 在美国,每年都有数以百万计的病人接受手术,通常是侵入性的和痛苦的 来矫正这些畸形。目前,自体组织移植或假体装置的植入是 用于治疗大面积缺损区。这些手术因缺乏供体组织而受到限制, 供体部位发病率、移植排斥反应的可能性、对感染的易感性以及移植的可行性。非- 可吸收材料,如钛,仍然是一种永久性的植入材料,缺乏重塑的能力。 用于与天然组织整合。我们提出了一类新的3D打印图形支架来模拟 骨骼的复杂性,并诱导天然的再生反应。 功能石墨材料(FGM)是一类新型的潜在支架材料,具有可调性 机械性能、可降解性和表面化学,这些都可以用来控制生物活性。 Sydlik团队已经开发出几种新型的功能梯度材料,这种材料在体外和体内都能诱导成骨。 具体地说,我们已经证明了磷酸钙石墨烯(CAPG)释放了具有生物教育意义的反离子,即钙离子。 和PO43-,自发地在小鼠模型中诱导体内成骨(PNAS,2019)。然而, 由于化学界面控制不充分,限制了功能梯度材料作为生物材料的应用 加工方法。因此,为了使这项技术可翻译,我们需要一种制造技术来创建 体积构造物,以填充较大的骨缺损。3D打印在应对这一挑战方面具有独特的定位 因为支架可以定制打印,以匹配患者的缺损处。这项建议旨在推进 生物活性成骨CAPG植入具有指导意义的支架,显著改善颅骨 再生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stefanie Arlene Sydlik其他文献

Stefanie Arlene Sydlik的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stefanie Arlene Sydlik', 18)}}的其他基金

An injectable block copolymer synthetic cartilage
可注射嵌段共聚物合成软骨
  • 批准号:
    8784250
  • 财政年份:
    2014
  • 资助金额:
    $ 19.17万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 19.17万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 19.17万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.17万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.17万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 19.17万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.17万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 19.17万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 19.17万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 19.17万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.17万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了